NLRC3 and hepatocellular carcinoma: Kaplan-Meier and log-rank tests showed that high CD8 was a prognosticator for improved overall survival (P = 0.0027; Figure 3E) and disease-free survival (P = 0.0277; Figure 3F), indicating that NLRC3 strengthens the prognostic value of CD8+ T cells for HCC.